International Atomic Energy Agency and SNMMI Sign Cooperative Agreement

October 23, 2017

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) have established practical arrangements to cooperate on extending the reach of educational materials for nuclear medicine diagnostic and therapeutic applications. The agreement was signed at the 30th Annual Congress of the European Association of Nuclear Medicine (EANM) in Vienna, Austria, on October 23, 2017.

 

Specifically, the organizations will cooperate on the development of interactive educational materials for the nuclear medicine component of the IAEA Human Health Campus. In addition, SNMMI will work with IAEA to

  • provide nuclear medicine professionals (or those in allied disciplines) from IAEA low- and middle-income member states with access to specific educational programs,
  • provide experts to support IAEA training activities,
  • include IAEA professionals in SNMMI training activities, and
  • facilitate the broadcasting of live web-streaming seminars on topics in nuclear medicine and molecular imaging.

“SNMMI looks forward to working with IAEA to advance nuclear medicine through cooperation on training and educational materials,” Greenspan said. “Broadening access to information will strengthen the knowledge of nuclear medicine professionals and enhance patient care.”

Such cooperation across borders improves healthcare around the globe. SNMMI welcomes this opportunity to work with IAEA and share knowledge.

Link to IAEA Press Release

###

Please visit the SNMMI Media Center for more information about molecular imaging and personalized medicine. To schedule an interview with SNMMI leadership, please contact Laurie Callahan at (703) 652-6773 or lcallahan@snmmi.org.

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising awareness about nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI’s more than 15,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.